Recent news and forthcoming events

Expanded tech-enabled data analytics capabilities strengthen Genesis Research Group’s integrated approach to market access, helping life sciences companies better navigate US market access hurdles Ki Park appointed Vice President, Market…

Genesis Research Group is attending ISPOR Europe from 17-20 November and taking part in multiple thought leadership sessions, including an Issue Panel and HEOR Theater. You can find them at…

Genesis Research Group, led by newly appointed CEO, David W. Miller, is spotlighted in June’s launch of ITN Business’ “Advancing Healthcare” program for its ‘innovate differently’ approach to supporting life…

A seasoned executive with more than 25 years in the biopharmaceutical industry, David Miller will lead the Group’s next phase of growth to revolutionize healthcare research. Frank A. Corvino appointed…

On 15 February 2024, Carole Longson and Allie Sosinsky of Genesis Research Group, a leading global provider of tech-enabled real-world evidence, market access, and HEOR solutions, will present a webinar…

Genesis Research Group, a leading provider of tech-enabled real-world evidence (RWE), health economics and outcomes research (HEOR), and market access services, announces the appointment of Lynn Okamoto as Chief Business…

Genesis Research Group, a leading provider of tech-enabled Real-World Evidence (RWE) and Health Economics and Outcomes Research (HEOR) services, has announced the appointment of Professor Carole Longson MBE and Dr.…

International health economics and outcomes research (HEOR) and real-world evidence (RWE) organization Genesis Research Group has announced the appointment of Jennifer Fillman as its new Chief Financial Officer. Prior to…

Genesis Research Group is delighted to announce a strategic partnership with Syapse®, a leading real-world evidence company dedicated to extinguishing the fear and burden of serious diseases by advancing real-world…

We are delighted to announce an exciting new partnership with Clinical Outcomes Assessment (COA) specialist Clinical Outcomes Solutions (COS). As the regulatory landscape with respect to RWE continues to evolve,…

From May 16-18, 2022, the Genesis Research Group leadership, including Joseph DiCesare, Frank A. Corvino, Marlene Smurzynski, Chris L. Pashos, Deborah Casso, Stephen Ralston, Weiying Wang, Julie Munakata, and Michael…

Genesis Research, a leading provider of tech-enabled Real-World Evidence (RWE) and Health Economics and Outcomes Research (HEOR) services, has acquired Market Access Transformation (“MAT”), a leading provider of technology-enabled payer…